| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C16orf90 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ATP1A3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ANKRD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | RAB17 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CXXC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | HRH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | GLIS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ART1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ZNF205 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | DNALI1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
